服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-TGFB1 mAbs [Metelimumab Biosimilar] (MABL-4931) | MABL-4931 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL5 mAbs [Mepolizumab Biosimilar] (MABL-4932) | MABL-4932 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Fel d 1 mAbs [Mevonlerbart Biosimilar] (MABL-4933) | MABL-4933 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-ADPRC1/CD38 mAbs [Mezagitamab Biosimilar] (MABL-4934) | MABL-4934 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-LEPR/CD295/OBR mAbs [Mibavademab Biosimilar] (MABL-4935) | MABL-4935 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-FN extracellular domain B mAbs [Micvotabart Biosimilar] (MABL-4936) | MABL-4936 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD74/HLA class II histocompatibility antigen gamma chain mAbs [Milatuzumab Biosimilar] (MABL-49 | MABL-4937 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL7R/CD127 mAbs [Lusvertikimab Biosimilar] (MABL-4911) | MABL-4911 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL1A;IL1B mAbs [Lutikizumab Biosimilar] (MABL-4912) | MABL-4912 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-NGF mAbs [Luvagrobart Biosimilar] (MABL-4913) | MABL-4913 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FOLR1 mAbs [Luveltamab Biosimilar] (MABL-4914) | MABL-4914 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Zaire Ebolavirus Glycoprotein mAbs [Maftivimab Biosimilar] (MABL-4915) | MABL-4915 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IAP/CD47 mAbs [Magrolimab Biosimilar] (MABL-4916) | MABL-4916 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDL1/CD274 mAbs [Manelimab Biosimilar] (MABL-4917) | MABL-4917 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-IL4R/CD124 mAbs [Manfidokimab Biosimilar] (MABL-4918) | MABL-4918 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-ERBB2/CD340/HER2 mAbs [Margetuximab Biosimilar] (MABL-4919) | MABL-4919 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-GIPR mAbs [Maridebart Biosimilar] (MABL-4920) | MABL-4920 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EGFR/ERBB1/HER1;CD28 mAbs [Marlotamig Biosimilar] (MABL-4921) | MABL-4921 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa;Kappa |
| Anti-ERBB2/CD340/HER2 mAbs [Marstacimab Biosimilar] (MABL-4922) | MABL-4922 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-Ganglioside GD2 mAbs [Lorukafusp Biosimilar] (MABL-4894) | MABL-4894 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn